Document Detail

Outcomes in biopsy-proven lupus nephritis: evaluation of 190 white patients from a single center.
MedLine Citation:
PMID:  20827107     Owner:  NLM     Status:  MEDLINE    
We describe the natural history of lupus nephritis (LN) in a historical cohort of 190 white patients with the diagnosis of biopsy-proven LN followed in a single reference center.We evaluated 670 patients with systemic lupus erythematosus (SLE) consecutively followed in our department from 1970 until 2006. All patients fulfilled the 1997 revised criteria for the classification of SLE. White patients (Spanish-born) with biopsy-proven LN were selected as the study population.The cohort included 190 patients (170 female patients and 20 male) with a mean age at LN diagnosis of 31 years. Renal biopsy revealed type I LN in 8 (4%) patients, type II in 33 (17%), type III in 46 (24%), type IV in 72 (38%), type V in 28 (15%), and type VI in 3 (2%) patients. Induction remission was achieved in 85% of patients with types I and II, 78% with type III, 70% with type IV, and 32% of patients with type V. After a mean follow-up of 2391 patient-years, 62 (33%) patients developed chronic renal failure and 18 (9%) evolved to end-stage renal disease. Adjusted multivariate Cox regression analysis identified male sex (hazard ratio [HR], 4.33) and elevated creatinine at LN diagnosis (HR, 5.18) as independent variables for renal failure. Survival was 92% at 10 years of follow-up, 80% after 20 years, and 72% after 30 years.Our results suggest that biopsy-proven LN in white patients has an excellent prognosis. Ethnicity should be considered a key factor when evaluating the prognosis and therapeutic response to different agents in patients with LN.
Antoni Sisó; Manuel Ramos-Casals; Albert Bové; Pilar Brito-Zerón; Natalia Soria; Norma Nardi; Adriana Testi; Marta Perez-de-Lis; Cándido Díaz-Lagares; Alejandro Darnell; Juan Sentís; Antonio Coca
Related Documents :
12653107 - Class v lupus nephritis: a clinicopathologic study in 152 patients.
3107577 - Anticardiolipin antibodies in patients with systemic lupus erythematosus.
7966067 - Clinical utility and serological connections of anti-ra33 antibodies in systemic lupus ...
2103307 - Longitudinal immunoblotting variations of auto-antibody reactivity of patients with sys...
8500247 - Spectral eeg parameters in patients with tick-borne encephalitis: a follow-up study.
20976097 - Facial emotion recognition impairment in patients with parkinson's disease and isolated...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Medicine     Volume:  89     ISSN:  1536-5964     ISO Abbreviation:  Medicine (Baltimore)     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-09     Completed Date:  2010-10-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985248R     Medline TA:  Medicine (Baltimore)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  300-7     Citation Subset:  AIM; IM    
Laboratory of Autoimmune Diseases Josep Font, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, and Hypertension Unit, Department of Internal Medicine (AC), Institut Clínic de Medicina i Dermatologia, Hospital Clínic, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Inflammatory Agents / adverse effects
Bacterial Infections / epidemiology
European Continental Ancestry Group / statistics & numerical data*
Glomerular Filtration Rate
Immunosuppressive Agents / adverse effects
Kidney / pathology
Kidney Failure, Chronic / drug therapy,  epidemiology,  pathology
Life Expectancy
Lupus Nephritis / drug therapy,  epidemiology*,  pathology*
Treatment Outcome
Virus Diseases / epidemiology
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Immunosuppressive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based stud...
Next Document:  Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the litera...